🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

In honor of #PSCAwarenessDay, learn more about primary sclerosing cholangitis, a rare disease where the bile ducts inside and outside the liver become inflamed and scarred, and eventually narrowed or blocked. 23andme.com/rare-disease-r…

We're heading to San Diego for the American Association for Cancer Research Annual Meeting to connect and share updates from the 23andMe Therapeutics team. Hope to see you there! More details: 23and.me/4aksIDV #AACR24

We're looking for a Sr. Bioinformatics Scientist to join our Research team! More details here: 23and.me/4aqlFJP

Today at #AACR24, our own Kim Gerrick is presenting at 3:20PM PST in Room 30, hope to see you there!

UPDATE: 23andMe to present preliminary efficacy & biomarker data for 23ME-00610 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting. More info here: 23and.me/ASCO24 #ASCO2024 #CancerResearch

Study in Nature Medicine shows having 2 copies of APOE4 may cause Alzheimer's, not just increase risk. This shows the value of genetic testing. Early diagnosis = early treatment. Knowledge is power! Read more: 23and.me/3UUNy7q #AlzheimersResearch #GeneticTesting #23andMe

In the latest edition of "Huh, I didn't expect that to work", our latest paper shows that LLMs can outperform existing methods for identifying causal genes in genome-wide association studies. 🧵 medrxiv.org/content/10.110…

Today we’re announcing a new study to advance research on lung cancer. While lung cancer research and targeted therapies have provided hope and progress for many, this study aims to learn more about the genetics behind the disease and its causes. More: 23and.me/3YjhWdH

In a preprint from the 23andMe Research team, we used Mendelian randomization to explore the genetically-predicted causal effects of Lp(a) on a range (n=489) of human traits and diseases. medrxiv.org/content/10.110…

We're looking for a scientific lead for our long standing (15 years!) Parkinson's disease research program. The program includes over 35k genotyped, consented individuals with PD. If you have a passion for PD and people living with PD, check it out: 23andme.com/careers/jobs/7…

Excited about our latest paper in Blood Advances. Blog post here: blog.23andme.com/articles/new-g…

A blog post on how our data can provide an edge for drug development blog.23andme.com/articles/a-new…

📌Publication alert: In a preprint from the 23andMe Research team, we conducted one of the largest GWAS study of Long COVID and identified genetic links of chronic conditions with Long COVID. medrxiv.org/content/10.110…

Our blog post on the same work, for the lay reader. blog.23andme.com/articles/genet…

Thanks in part to 23andMe research participants, Institute for Molecular Bioscience demonstrated that women with a high genetic risk of developing depression are more likely to develop heart disease. imb.uq.edu.au/article/2024/1…

We are hiring for a postdoc to work on the genetics of autism. Come join our team! 23andme.com/careers/jobs/7…

How can you power drug development with evidence from the world’s largest recontactable genetics community? Find out here! 23andme.com/partner/

New landmark study led by The University of Edinburgh and King's College London looking at genomes of 5M+ people across 29 countries — including 23andMe customers who consented to participate in research — uncovered ~300 previously unknown genetic links to depression. 23and.me/DepressionGene…

We are excited about the many positive conversations we had at the JP Morgan meeting this year, on the heels of our Discover23 press release. Looking forward to many more research collabs! investors.23andme.com/news-releases/…